{"uid":"b7882397fd0ec4cc","name":"TEST-SPO-116378.01","historyId":"METTA-WAM-ISSUE-116:METTA-WAM-ISSUE-116#TEST-SPO-116378.01","time":{"start":1728427334000,"stop":1728427380424,"duration":46424},"status":"passed","flaky":false,"newFailed":false,"newBroken":false,"newPassed":false,"retriesCount":0,"retriesStatusChange":false,"beforeStages":[],"testStage":{"steps":[{"name":"<![CDATA[","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"<a href=\"https://trueagi-io.github.io/metta-wam/reports/tests_output/baseline-compat/tests/baseline_compat/anti-regression/issues/metta-wam-issue-116/test_spo_116378.metta.0_failed.html#METTA-WAM-ISSUE-116.TEST-SPO-116378.01\">Test Report</a>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Assertion: (assertEqualToResult (match &hald116378 (Doxorubicin $p $o) (Doxorubicin $p $o)))","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Expected: ((Doxorubicin needed Cardiotoxicity) (Doxorubicin treat Rituximab) (Doxorubicin prolong Neoplasms) (Doxorubicin show Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin show Neoplasms) (Doxorubicin show Glioma) (Doxorubicin exhibit Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin exhibit Neoplasms) (Doxorubicin accumulate Brain_Neoplasms) (Doxorubicin monitor Neoplasms) (Doxorubicin sever Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin given Hemangiosarcoma) (Doxorubicin differ Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin elevated Trastuzum...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Actual: ((Doxorubicin stratify Liposarcoma) (Doxorubicin associated MIR375) (Doxorubicin elevated Trastuzumab) (Doxorubicin include Trastuzumab) (Doxorubicin associated Cardiotoxicity) (Doxorubicin accepted 'Lymphoma,_B-Cell') (Doxorubicin represent Breast_Neoplasms) (Doxorubicin combine Breast_Neoplasms) (Doxorubicin fit Breast_Neoplasms) (Doxorubicin lead Death) (Doxorubicin cause Cardiotoxicity) (Doxorubicin stimulate Ischemia) (Doxorubicin induce CDKN2A) (Doxorubicin affect Cardiomyopathies) (Doxorubicin evaluate CAT) (Doxorubicin evaluate GSR) (Doxorubicin evaluate Lipid_Peroxides) (Doxorubicin e...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"]]>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false}],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":7,"attachmentsCount":0,"hasContent":true,"attachmentStep":false},"afterStages":[],"labels":[{"name":"resultFormat","value":"junit"},{"name":"suite","value":"METTA-WAM-ISSUE-116"},{"name":"testClass","value":"METTA-WAM-ISSUE-116"},{"name":"package","value":"METTA-WAM-ISSUE-116"}],"parameters":[],"links":[],"hidden":false,"retry":false,"extra":{"severity":"normal","retries":[],"categories":[],"history":{"statistic":{"failed":0,"broken":0,"skipped":0,"passed":39,"unknown":0,"total":39},"items":[{"uid":"9df694b8eb6eb60c","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/313//#testresult/9df694b8eb6eb60c","status":"passed","time":{"start":1728426243000,"stop":1728426288724,"duration":45724}},{"uid":"266c8c2714b9c0d0","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/311//#testresult/266c8c2714b9c0d0","status":"passed","time":{"start":1728349822000,"stop":1728349868989,"duration":46989}},{"uid":"61f5a29ac689c5c6","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/310//#testresult/61f5a29ac689c5c6","status":"passed","time":{"start":1728324085000,"stop":1728324132552,"duration":47552}},{"uid":"3ef982ede334a7f6","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/309//#testresult/3ef982ede334a7f6","status":"passed","time":{"start":1728323941000,"stop":1728323987003,"duration":46003}},{"uid":"9c819ea75c31bf8e","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/308//#testresult/9c819ea75c31bf8e","status":"passed","time":{"start":1728321881000,"stop":1728321927181,"duration":46181}},{"uid":"c19c53e43e28b2f7","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/307//#testresult/c19c53e43e28b2f7","status":"passed","time":{"start":1728321507000,"stop":1728321553670,"duration":46670}},{"uid":"e17b620ec247383d","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/304//#testresult/e17b620ec247383d","status":"passed","time":{"start":1728103138000,"stop":1728103183737,"duration":45737}},{"uid":"d40136ca14b3807d","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/303//#testresult/d40136ca14b3807d","status":"passed","time":{"start":1728103024000,"stop":1728103070440,"duration":46440}},{"uid":"288e8fa31f305ae1","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/302//#testresult/288e8fa31f305ae1","status":"passed","time":{"start":1728102766000,"stop":1728102812489,"duration":46489}},{"uid":"ba850b1a18ee5409","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/300//#testresult/ba850b1a18ee5409","status":"passed","time":{"start":1728091962000,"stop":1728092008542,"duration":46542}},{"uid":"d59f2838651b2754","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/299//#testresult/d59f2838651b2754","status":"passed","time":{"start":1728091255000,"stop":1728091302318,"duration":47318}},{"uid":"227d64d88a6a36e8","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/298//#testresult/227d64d88a6a36e8","status":"passed","time":{"start":1728090967000,"stop":1728091014036,"duration":47036}},{"uid":"59e19aa26eda6ef5","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/297//#testresult/59e19aa26eda6ef5","status":"passed","time":{"start":1728089001000,"stop":1728089047465,"duration":46465}},{"uid":"9196663154dd1af0","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/296//#testresult/9196663154dd1af0","status":"passed","time":{"start":1728082697000,"stop":1728082743144,"duration":46144}},{"uid":"689d11b806c981cd","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/295//#testresult/689d11b806c981cd","status":"passed","time":{"start":1728079929000,"stop":1728079975049,"duration":46049}},{"uid":"2aed7be919b72bc9","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/294//#testresult/2aed7be919b72bc9","status":"passed","time":{"start":1728075697000,"stop":1728075743095,"duration":46095}},{"uid":"723cc0de724265f9","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/293//#testresult/723cc0de724265f9","status":"passed","time":{"start":1728020017000,"stop":1728020063146,"duration":46146}},{"uid":"babc990ce30f3bea","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/292//#testresult/babc990ce30f3bea","status":"passed","time":{"start":1728019432000,"stop":1728019478479,"duration":46479}},{"uid":"dad86e395c46ba5b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/291//#testresult/dad86e395c46ba5b","status":"passed","time":{"start":1728018121000,"stop":1728018169014,"duration":48014}},{"uid":"6ca3614c1962c45b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/289//#testresult/6ca3614c1962c45b","status":"passed","time":{"start":1728004244000,"stop":1728004290037,"duration":46037}}]},"tags":[]},"source":"b7882397fd0ec4cc.json","parameterValues":[]}